Make your money go further for just 25p per day

PREMIUM

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Alphabet (GOOGL)  · Apple (AAPL)  · AstraZeneca (AZN)  · GSK (GSK)  · Novartis (NOVN)  · Nvidia (NVDA)  · Uber Technologies (UBER) 

UK US

Image in style of Monet illustrating AI

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors as we consider here, with three sectors set to be big winners. 


Remember to listen to Episode 24 of the Investor’s Champion Podcast

In this episode of the Investors Champion podcast, hosts Chris and Lee focus on the world of small caps and AIM. Topics include a discussion of YouGov’s profit warning, the contrasting fortunes of AIM’s cosmetics companies, a bizarre franchise creation and Supreme’s strange acquisition. Other companies covered include, Intercede, Chapel Down, Gear4Music, Time Finance, and PCI PAL. The episode also touches on notable market activities…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alphabet

Episode 41 of the Investor’s Champion Podcast

17/03/2025 · Podcasts

Following an eye-opening reporting season, in this podcast, hosts Chris and Lee discuss the performance of…


Ultimate Stocks Portfolio: something for everyone

11/02/2025 · Portfolio

Our portfolio of high-quality companies offers something for everyone, as you will appreciate in another of…


More on Apple

Episode 41 of the Investor’s Champion Podcast

17/03/2025 · Podcasts

Following an eye-opening reporting season, in this podcast, hosts Chris and Lee discuss the performance of…


When knocking the lights out isn’t enough

28/02/2025 · Portfolio

As results season draws to a close several of our high quality companies have delivered fabulous…


More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


More on GSK

Income Boosters update - 7.8% dividend yield

07/03/2025 · Portfolio

Our high yield portfolio boasts a potential 7.8% dividend yield. We review recent results and discuss…


Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


More on Novartis

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP